Maternal Pertussis Vaccination Linked to Lower Infection Risk in Infants
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 10, 2023 -- Maternal pertussis vaccination is associated with a reduced risk for infection among infants through 8 months of age, according to a study published online Oct. 9 in Pediatrics.
Annette K. Regan, Ph.D., from Curtin University in Perth, Australia, and colleagues conducted a population-based cohort study of 279,418 mother-infant pairs to estimate maternal vaccine effectiveness (VE) and whether maternal pertussis vaccination modifies the effectiveness of the first three infant doses of pertussis-containing vaccines.
The researchers found that pertussis was administered during 51.7 percent of pregnancies, mainly at 28 to 31 weeks of gestation. There was a decline seen in VE of maternal vaccination from 70.4 to 43.3 percent among infants younger than 2 months old versus those aged 7 to 8 months; VE was not significant after 8 months of age. Slightly lower VE point estimates were seen for the third dose of infant pertussis vaccine among maternally vaccinated versus unvaccinated infants (76.5 versus 92.9 percent), but the rates of pertussis infection were not higher.
"These results indicate that maternal pertussis vaccination protects infants from pertussis infection during a period of greatest vulnerability to severe morbidity and mortality," the authors write. "Our findings support the infant health benefits of recommendations to administer a booster dose of pertussis vaccine near 28 weeks of gestational age."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma Symptoms
WEDNESDAY, July 3, 2024 -- Higher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter...
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine
FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.